Related Experiment Videos
Therapeutic potential of complement inhibitors in myocardial ischaemia
1Department of Pharmacology, University of Michigan, A220C, 1301 MSRB III, 1150 West Medical Center Drive, Ann Arbor, MI 48019-0632, USA.
Insights
The complement system, crucial for pathogen defense, exacerbates myocardial reperfusion injury by promoting inflammation and tissue damage. Inhibitors are being developed to mitigate this complement-mediated damage in heart attacks.
Area of Science:
- Immunology
- Cardiovascular Biology
- Inflammation Research
Background:
- The complement system normally clears pathogens but contributes to tissue damage in inflammatory conditions.
- Complement activation is a key factor in myocardial reperfusion injury, leading to irreversible heart tissue damage.
- Current clinical use of complement inhibitors for reperfusion injury is limited.
Purpose of the Study:
- To provide an overview of complement system activation and its role in myocardial ischemia/reperfusion injury.
- To examine endogenous and exogenous inhibitors of the complement cascade.
- To discuss complement activation and inhibition in the context of myocardial reperfusion injury.
Main Methods:
- Review of complement system function in microbial eradication and inflammatory disorders.
- Analysis of complement-mediated tissue damage mechanisms, including anaphylatoxins, opsonins, and the membrane attack complex (MAC).
- Examination of complement cascade fragments (C3a, C5a) and their role in recruiting inflammatory cells.
Main Results:
- Complement activation generates anaphylatoxins, opsonins, and the MAC, contributing to myocardial infarction.
- Complement fragments recruit and activate inflammatory cells like neutrophils and macrophages, worsening myocyte damage.
- Damaged tissue can upregulate complement protein production, amplifying injury through MAC assembly.
Conclusions:
- The complement system plays a dual role, protecting against pathogens but causing damage during ischemia/reperfusion.
- Understanding complement activation pathways and inhibitors is crucial for developing treatments for myocardial reperfusion injury.
- Further research into complement inhibitors holds promise for reducing irreversible tissue damage after heart attacks.
Abstract:
Under normal conditions, the complement system functions to eradicate microbes and other membrane bound pathogens. In other situations, complement activation comprises a pivotal mechanism for mediating tissue demolition in inflammatory disorders, including ischaemia/reperfusion injury. Complement-mediated tissue damage has long been recognised as a significant contributor to myocardial reperfusion injury. However, clinical use of complement inhibitors to reduce the extent of irreversible tissue injury related to reperfusion, remains in the early stages of development. Activation of the complement system generates anaphylatoxins, opsonins and the lytic moiety known as the membrane attack complex (MAC). In addition, fragments of the complement cascade proteins (e.g., C3a and C5a) secondarily initiate processes deleterious to myocytes by recruiting and stimulating inflammatory cells, such as neutrophils and macrophages, within the area of reperfusion. Damaged tissue itself, is capable of upregulating the genes that encode the formation of complement proteins leading to assembly of the MAC, which in turn further advances tissue injury. All of these factors contribute to the development of myocardial infarction subsequent to ischaemia and reperfusion. This paper provides an overview of how the complement system operates and examines the various inhibitors, both endogenous and exogenous, that regulate the complement cascade. Activation and inhibition of the complement system will be discussed primarily in the context of myocardial ischaemia and reperfusion injury.